All data are based on the daily closing price as of October 22, 2024
s
Seegene
096530.KQ
16.94 USD
-0.31
-1.80%
Overview
Last close
16.94 usd
Market cap
782.93M usd
52 week high
25.77 usd
52 week low
13.86 usd
Target price
37.77 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2.8151
Price/Book Value
1.055
Enterprise Value
523.38M usd
EV/Revenue
1.8859
EV/EBITDA
7.2074
Key financials
Revenue TTM
277.52M usd
Gross Profit TTM
359.94M usd
EBITDA TTM
33.90M usd
Earnings per Share
N/A usd
Dividend
0.58 usd
Total assets
1,267.64B usd
Net debt
N/A usd
About
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.